What treatment of revenue recognition is required by AASB 141?
A) Revenue should be recognised in the income statement on the sale of the asset. Losses should be recognised as a result of a write-down to recoverable amount.
B) Changes in the net market values of biological assets that relate to volume changes must be recognised as revenues or expenses as appropriate in the profit and loss statement.
C) Changes in the current replacement cost of biological assets should be treated as adjustments to the asset revaluation reserve. Revenues should be recognised on the sale of the asset and matched against the replacement cost of the asset sold.
D) Increments and decrements in the net market values of biological assets must be recognised as revenues or expenses in the profit and loss statement for the financial year in which the increments or decrements occur.
E) None of the given answers.
Correct Answer:
Verified
Q49: Which of the following statements is correct
Q50: Where a biological asset is not separable
Q51: Which of the following items are not
Q52: AASB 141 states that where no active
Q53: What is the accounting treatment for a
Q55: Nerang Orange Farms Ltd has orange tress
Q56: Which of the following items are not
Q57: One approach to revenue recognition proposed for
Q58: Lynne-Melinda Ltd operates a large scale lavender
Q59: Lynne-Melinda Ltd operates a large scale lavender
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents